Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC15337Berzosertib (VE-822)CAS: 1232416-25-9
Berzosertib (VE-822)是一种静脉给药的、高度强效且选择性的ATR抑制剂(IC 50 =19nM)。
- GC15363Felbamate hydrateCAS: 1177501-39-1
An inhibitor of NMDA receptors and a modulator of GABA A receptors
- GC15371BardoxoloneCAS: 218600-44-3纯度: >98.00%
An anti-inflammatory compound that activates Nrf2/ARE signaling
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC15311 | BP 554 maleate | 82900-57-0 | - | |
Selective 5-HT1A agonist | ||||
| GC15312 | Chlorprothixene | 113-59-7 | >99.00% | |
A dopamine D 2 receptor antagonist | ||||
| GC15315 | Scriptaid | 287383-59-9 | >98.50% | |
HDAC inhibitor | ||||
| GC15317 | SB408124 | 288150-92-5 | >98.50% | |
A potent orexin 1 receptor antagonist | ||||
| GC15318 | GW501516 | 317318-70-0 | >99.00% | |
GW501516是一种合成PPARδ特异性激动剂,EC 50 值为0.10nM。 | ||||
| GC15324 | Hexestrol | 84-16-2 | >98.00% | |
A synthetic non-steroidal estrogen receptor ligand | ||||
| GC15331 | Prednisolone | 50-24-8 | >98.00% | |
The active metabolite of prednisone | ||||
| GC15332 | Ticagrelor | 274693-27-5 | >99.50% | |
A reversible purinergic P2Y 12 receptor antagonist | ||||
| GC15335 | Saquinavir | 127779-20-8 | >99.00% | |
Saquinavir (Ro 31-8959) 是一种 HIV 蛋白酶抑制剂,用于抗逆转录病毒治疗。 | ||||
| GC15337 | Berzosertib (VE-822) | 1232416-25-9 | - | |
Berzosertib (VE-822)是一种静脉给药的、高度强效且选择性的ATR抑制剂(IC 50 =19nM)。 | ||||
| GC15344 | SP 600125 | 129-56-6 | >98.00% | |
SP 600125是一种具有口服活性的、可逆的、具有选择性的ATP竞争性JNK 抑制剂,对JNK1、JNK2和JNK3的IC 50 分别为40、40和90nM。SP 600125常用于卵巢癌、肿瘤、帕金森病 (PD)、乳腺癌和哮喘的研究。 | ||||
| GC15348 | Pyridostigmine Bromide | 101-26-8 | >98.00% | |
An inhibitor of AChE and BChE | ||||
| GC15353 | Iniparib (BSI-201) | 160003-66-7 | >99.50% | |
A PARP1 inhibitor | ||||
| GC15358 | PF 750 | 959151-50-9 | >98.00% | |
A selective, potent FAAH inhibitor | ||||
| GC15359 | SL-327 | 305350-87-2 | >98.00% | |
SL-327是MEK1和MEK2的选择性抑制剂,IC 50 值分别为0.18μM和0.22μM。 | ||||
| GC15363 | Felbamate hydrate | 1177501-39-1 | - | |
An inhibitor of NMDA receptors and a modulator of GABA A receptors | ||||
| GC15366 | Clomiphene citrate | 50-41-9 | >98.00% | |
A selective estrogen receptor modulator | ||||
| GC15371 | Bardoxolone | 218600-44-3 | >98.00% | |
An anti-inflammatory compound that activates Nrf2/ARE signaling | ||||
| GC15373 | (E)-2-Decenoic acid | 334-49-6 | >98.00% | |
An unsaturated fatty acid found in royal jelly | ||||
| GC15374 | BD 1047 dihydrobromide | 138356-21-5 | >98.00% | |
A selective antagonist of σ 1 receptors | ||||
| GC15380 | PF-562271 | 717907-75-0 | >99.50% / >98.00% | |
PF-562271是一种针对黏着斑激酶(FAK) 和富含脯氨酸的酪氨酸激酶2(Pyk2)的强效小分子抑制剂,IC 50 分别为1.5nmol/L和14nmol/L。 | ||||
| GC15382 | Isotretinoin | 4759-48-2 | >99.50% | |
A retinoid | ||||
| GC15389 | 360A | 794458-56-3 | - | |
360A 是 G-quadruplex 的选择性稳定剂,也抑制端粒酶活性,在 TRAP-G4 试验中对端粒酶的 IC50 为 300 nM。 | ||||
| GC15390 | Dabigatran etexilate mesylate | 872728-81-9 | >98.00% | |
A prodrug form of dabigatran | ||||
